PAULA ZIMMER: Open Payments
NPI 1700816568 · GLENS FALLS, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,216 in 20 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $249 · 2025 $2,216
Food & beverage: $2,216
| Company | Payments | Amount |
|---|---|---|
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 3 | $335 |
| Boston Scientific Corporation | 3 | $331 |
| Viatris Specialty LLC | 2 | $240 |
| Neurelis, Inc. | 2 | $234 |
| Janssen Pharmaceuticals, Inc | 2 | $223 |
| Madrigal Pharmaceuticals | 1 | $135 |
| UCB, Inc. | 1 | $128 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $127 |
| Novo Nordisk Inc | 1 | $123 |
| CVRx, Inc. | 1 | $104 |
Products named: WaveWriter Alpha Prime 16, YUPELRI, VALTOCO, INVEGA SUSTENNA, REZDIFFRA, Rystiggo, Kerendia, Wegovy.
Industry payments across NY — which companies pay providers there.
